STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinoma

BACKGROUND: Pancreatic ductal adenocarcinoma (PDA) is a highly lethal cancer characterized by complex aberrant genomes. A fundamental goal of current studies is to identify those somatic events arising in the variable landscape of PDA genomes that can be exploited for improved clinical outcomes. MET...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Evers, Lisa, Perez-Mancera, Pedro A, Lenkiewicz, Elizabeth, Tang, Nanyun, Aust, Daniela, Knösel, Thomas, Rümmele, Petra, Holley, Tara, Kassner, Michelle, Aziz, Meraj, Ramanathan, Ramesh K, Von Hoff, Daniel D, Yin, Holly, Pilarsky, Christian, Barrett, Michael T
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2014
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3971348/
https://ncbi.nlm.nih.gov/pubmed/24484537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/gm526
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires